# 2026-13346: FDA Seeks Comments on Medication Guide Reporting Rules

2026-13346, Agency Information Collection Activities; Submission for Office of Management and Budget Review; Comment Request; Medication Guides for Prescription Drug Products, is a Federal Register notice from Health and Human Services Department, Food and Drug Administration published 2026-07-01, effective Submit written comments (including recommendations) on the collection of information by July 31, 2026.; PRIA reads it as touching household money (as of 2026-07-08).

- Canonical: https://policyrisk.com/federal-register/2026-13346
- As of: 2026-07-08
- Plain-text twin of the page above; the HTML and this file carry the same facts.

## Facts
- Document number: 2026-13346
- Title: Agency Information Collection Activities; Submission for Office of Management and Budget Review; Comment Request; Medication Guides for Prescription Drug Products
- Type: Notice
- Agencies: Health and Human Services Department; Food and Drug Administration
- Citation: 91 FR 40000
- Published: 2026-07-01
- Effective: Submit written comments (including recommendations) on the collection of information by July 31, 2026.
- Comments close: 2026-07-31
- Significant: no
- Touches household money: yes
- Regulation identifier numbers: none
- Last updated: 2026-07-08

## In one line

FDA Seeks Comments on Medication Guide Reporting Rules

## Summary

The FDA is updating how it collects info about Medication Guides—those important leaflets that come with some prescription drugs to keep patients safe. This affects drug makers who must follow new rules about what info to include and how to share it. Comments on these changes are open until July 31, 2026, and the update aims to keep patients informed without adding extra costs.

## Abstract

The Food and Drug Administration (FDA) is announcing that a proposed collection of information has been submitted to the Office of Management and Budget (OMB) for review and clearance under the Paperwork Reduction Act of 1995.

## Effects PRIA read

- Drug Sponsors Must Submit Medication Guides: cost, high. If you are a holder of a new drug application, FDA expects 70 application holders to prepare and submit one Medication Guide annually. FDA estimates each submission takes 320 hours on average, totaling 22,400 hours across all sponsors.
- Manufacturers Must Ensure Adequate Guide Supply: cost, high. Manufacturers who hold relevant applications must ensure distributors and authorized dispensers have an adequate supply or means to produce Medication Guides. FDA estimates 70 manufacturers will make an average of 9,000 disclosures each annually, with an average 1.25 hours per disclosure, totaling…
- Distributors Must Provide Guides to Pharmacies: cost, high. Distributors that ship drugs requiring Medication Guides must provide the Guide or the means to produce it to authorized dispensers. FDA estimates 191 such distributors will each make 9,000 disclosures annually, with 1.25 hours per disclosure, totaling 2,148,750 hours.
- Pharmacies' Dispensing Time Estimated at 10 Seconds: cost, high. Authorized dispensers (pharmacies) are expected to dispense Medication Guides to patients; FDA estimates 88,736 authorized dispensers will each distribute to 5,705 patients annually, for a total of 506,238,880 dispensings. FDA attributes 10 seconds (0.0027 hours) of burden per dispensing, totaling…
- Net Change: Hours Decrease, Responses Increase: mixed, high. FDA states that after adjusting estimates, the information collection reflects a decrease of 22,938,375 hours and an increase of 4,829,782 responses annually related to Medication Guide requirements.

## Related documents

- [2026-20848](https://policyrisk.com/federal-register/2026-20848): Use of Salt Substitutes To Reduce the Sodium Content in Standardized Foods, 2026-10-13
- [2026-16296](https://policyrisk.com/federal-register/2026-16296): Substances Generally Recognized as Safe, 2026-08-11
- [2026-14073](https://policyrisk.com/federal-register/2026-14073): Drug Establishment Registration and Drug Listing Requirements for Establishments Engaged in Distributed Manufacturing and Certain Foreign E…, 2026-07-13
- [2026-13047](https://policyrisk.com/federal-register/2026-13047): Establishment Registration and Product Listing for Tobacco Products, 2026-06-29
- [2025-04978](https://policyrisk.com/federal-register/2025-04978): Nonprescription Drug Product With an Additional Condition for Nonprescription Use, 2025-03-25
- [2025-01840](https://policyrisk.com/federal-register/2025-01840): Nonprescription Drug Product With an Additional Condition for Nonprescription Use, 2025-01-27

## Sources
- [2026-13346 on federalregister.gov](https://www.federalregister.gov/documents/2026/07/01/2026-13346/agency-information-collection-activities-submission-for-office-of-management-and-budget-review)
- [2026-13346 as published (PDF)](https://www.govinfo.gov/content/pkg/FR-2026-07-01/pdf/2026-13346.pdf)

## Related
- [Previous: 2026-13345, Steel Concrete Reinforcing Bar From the Republic of Tuumlrkiye: Final Results…](https://policyrisk.com/federal-register/2026-13345)
- [Next: 2026-13312, Notice of Inventory Completion: University of Rhode Island, Kingston, RI](https://policyrisk.com/federal-register/2026-13312)
- [All Federal Register documents](https://policyrisk.com/federal-register)

Source: PRIA, https://policyrisk.com/federal-register/2026-13346 (as of 2026-07-08).
